Literature DB >> 10825127

Estradiol induces functional inactivation of p53 by intracellular redistribution.

A M Molinari1, P Bontempo, E M Schiavone, V Tortora, M A Verdicchio, M Napolitano, E Nola, B Moncharmont, N Medici, V Nigro, I Armetta, C Abbondanza, G A Puca.   

Abstract

Estrogen treatment of MCF-7 cells grown in serum-free medium induced a modification of the intracellular distribution of p53 protein. Western blot analysis and immunofluorescence staining showed that p53 was localized in the nucleus of untreated cell and that after 48 h of hormone treatment, it was mostly localized in the cytoplasm. This effect was blocked by the antiestrogen ICI182,780. Intracellular redistribution of p53 was correlated to a reduced expression of the WAF1/CIP1 gene product and to the presence of degradation fragments of p53 in the cytosol. Estradiol treatment prevented the growth inhibition induced by oligonucleotide transfection, simulating DNA damage. This observation indicated that the wild-type p53 gene product present in the MCF-7 cell could be inactivated by estradiol through nuclear exclusion to permit the cyclin-dependent phosphorylation events leading to the G1-S transition. In addition, the estradiol-induced inactivation of p53 could be involved in the tumorigenesis of estrogen-dependent neoplasm.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825127

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen-induced cellular senescence.

Authors:  Rebecca Tuttle; Kelly R Miller; J Nicholas Maiorano; Paula M Termuhlen; Yongping Gao; Steven J Berberich
Journal:  Int J Cancer       Date:  2011-08-09       Impact factor: 7.396

2.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.

Authors:  S Sengupta; B Wasylyk
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

3.  Zebrafish (Danio rerio) life-cycle exposure to chronic low doses of ethinylestradiol modulates p53 gene transcription within the gonads, but not NER pathways.

Authors:  J Soares; L Filipe C Castro; M A Reis-Henriques; N M Monteiro; M M Santos
Journal:  Ecotoxicology       Date:  2012-04-28       Impact factor: 2.823

4.  Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture.

Authors:  Michael S Weiss; Beatriz Peñalver Bernabé; Abigail D Bellis; Linda J Broadbelt; Jacqueline S Jeruss; Lonnie D Shea
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

Review 5.  The p53-estrogen receptor loop in cancer.

Authors:  C Berger; Y Qian; X Chen
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

6.  Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.

Authors:  H Karimi Kinyamu; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

7.  A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.

Authors:  Angelika Brekman; Kathryn E Singh; Alla Polotskaia; Nandini Kundu; Jill Bargonetti
Journal:  Breast Cancer Res       Date:  2011-01-11       Impact factor: 6.466

Review 8.  Estrogen signaling and the DNA damage response in hormone dependent breast cancers.

Authors:  C Elizabeth Caldon
Journal:  Front Oncol       Date:  2014-05-14       Impact factor: 6.244

9.  Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.

Authors:  Amanda Cañas; Laura M López-Sánchez; Araceli Valverde-Estepa; Vanessa Hernández; Elena Fuentes; Juan R Muñoz-Castañeda; Chary López-Pedrera; Juan R De La Haba-Rodríguez; Enrique Aranda; Antonio Rodríguez-Ariza
Journal:  Breast Cancer Res       Date:  2012-12-05       Impact factor: 6.466

10.  Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.

Authors:  Alan S Coates; Ewan K A Millar; Sandra A O'Toole; Timothy J Molloy; Giuseppe Viale; Aron Goldhirsch; Meredith M Regan; Richard D Gelber; Zhuoxin Sun; Monica Castiglione-Gertsch; Barry Gusterson; Elizabeth A Musgrove; Robert L Sutherland
Journal:  Breast Cancer Res       Date:  2012-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.